{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:33:48Z","timestamp":1795059228735,"version":"4.10.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The coronavirus disease (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread to &gt;200 countries posing a global public health concern. Patients with comorbidity, such as hypertension suffer more severe infection with elevated mortality. The development of effective antiviral drugs is in urgent need to treat COVID-19 patients. Here, we report that calcium channel blockers (CCBs), a type of antihypertensive drug that is widely used in clinics, inhibited the post-entry replication events of SARS-CoV-2 in vitro, while no in vitro anti-SARS-CoV-2 effect was observed for the two other major types of antihypertensive drugs, namely, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. CCB combined with chloroquine showed a significantly enhanced anti-SARS-CoV-2 efficacy. A retrospective clinical investigation on hospitalized COVID-19 patients with hypertension as the only comorbidity revealed that the CCB amlodipine besylate therapy was associated with a decreased case fatality rate. The results from this study suggest that CCB administration to COVID-19 patients with hypertension as the comorbidity might improve the disease outcome.<\/jats:p>","DOI":"10.1038\/s41421-020-00235-0","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T20:02:42Z","timestamp":1608580962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-2571","authenticated-orcid":false,"given":"Lei-Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-7436","authenticated-orcid":false,"given":"Yuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Juan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Nian","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-7277","authenticated-orcid":false,"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0172-8725","authenticated-orcid":false,"given":"Ke","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengfu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"235_CR1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"235_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"235_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"235_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"G Li","year":"2020","unstructured":"Li, G. & De Clercq, E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat. Rev. Drug Discov. 19, 149\u2013150 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"235_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res."},{"key":"235_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.imlet.2013.07.004","volume":"153","author":"R Thome","year":"2013","unstructured":"Thome, R., Lopes, S. C., Costa, F. T. & Verinaud, L. Chloroquine: modes of action of an undervalued drug. Immunol. Lett. 153, 50\u201357 (2013).","journal-title":"Immunol. Lett."},{"key":"235_CR7","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","volume":"382","author":"J Geleris","year":"2020","unstructured":"Geleris, J. et al. Observational study of hydroxychloroquine in hospitalized patients with covid-19. N. Engl. J. Med. 382, 2411\u20132418 (2020).","journal-title":"N. Engl. J. Med."},{"key":"235_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren, T. K. et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature 531, 381\u2013385 (2016).","journal-title":"Nature"},{"key":"235_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653","volume":"9","author":"TP Sheahan","year":"2017","unstructured":"Sheahan, T. P. et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med. 9, eaal3653 (2017).","journal-title":"Sci. Transl. Med."},{"key":"235_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"TP Sheahan","year":"2020","unstructured":"Sheahan, T. P. et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat. Commun. 11, 222 (2020).","journal-title":"Nat. Commun."},{"key":"235_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 - preliminary report. N. Engl. J. Med. 383, 993\u2013994 (2020).","journal-title":"N. Engl. J. Med."},{"key":"235_CR12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","volume":"6","author":"Q Cai","year":"2020","unstructured":"Cai, Q. et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering 6, 1192\u20131198, https:\/\/doi.org\/10.1016\/j.eng.2020.03.007 (2020).","journal-title":"Engineering"},{"key":"235_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"235_CR14","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury\u2014Calcium Channel Blockers (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012)."},{"key":"235_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","volume":"29","author":"H Li","year":"2019","unstructured":"Li, H. et al. Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality. Cell Res. 29, 739\u2013753 (2019).","journal-title":"Cell Res."},{"key":"235_CR16","doi-asserted-by":"publisher","first-page":"204ra131","DOI":"10.1126\/scitranslmed.3006827","volume":"5","author":"M Lavanya","year":"2013","unstructured":"Lavanya, M., Cuevas, C. D., Thomas, M., Cherry, S. & Ross, S. R. siRNA screen for genes that affect Junin virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci. Transl. Med. 5, 204ra131 (2013).","journal-title":"Sci. Transl. Med."},{"key":"235_CR17","first-page":"e01055","volume":"91","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Screening of FDA-approved drugs for inhibitors of Japanese Encephalitis Virus Infection. J. Virol. 91, e01055\u201317 (2017).","journal-title":"J. Virol."},{"key":"235_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061\u20131069 (2020).","journal-title":"JAMA"},{"key":"235_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang, L., Karakiulakis, G. & Roth, M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 8, e21 (2020).","journal-title":"Lancet Respir. Med."},{"key":"235_CR20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","volume":"395","author":"FJ de Abajo","year":"2020","unstructured":"de Abajo, F. J. et al. Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet 395, 1705\u20131714 (2020).","journal-title":"Lancet"},{"key":"235_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1054\/ceca.2000.0163","volume":"29","author":"L Missiaen","year":"2001","unstructured":"Missiaen, L., Callewaert, G., De Smedt, H. & Parys, J. B. 2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. Cell Calcium 29, 111\u2013116 (2001).","journal-title":"Cell Calcium"},{"key":"235_CR22","first-page":"e426","volume":"138","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation 138, e426\u2013e483 (2018). 2017.","journal-title":"Circulation"},{"key":"235_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006752","volume":"15","author":"A Malyutina","year":"2019","unstructured":"Malyutina, A. et al. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer. PLoS Comput. Biol. 15, e1006752 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"235_CR24","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"A Ianevski","year":"2017","unstructured":"Ianevski, A., He, L., Aittokallio, T. & Tang, J. SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics 33, 2413\u20132415 (2017).","journal-title":"Bioinformatics"},{"key":"235_CR25","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/jcm9051417","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Hypertension, thrombosis, kidney failure, and diabetes: is covid-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J. Clin. Med. 9, 1417 (2020).","journal-title":"J. Clin. Med."},{"key":"235_CR26","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"235_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01047-y","volume":"19","author":"C Sardu","year":"2020","unstructured":"Sardu, C., Gargiulo, G., Esposito, G., Paolisso, G. & Marfella, R. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19. Cardiovasc. Diabetol. 19, 76 (2020).","journal-title":"Cardiovasc. Diabetol."},{"key":"235_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.diabet.2020.05.005","volume":"46","author":"R Marfella","year":"2020","unstructured":"Marfella, R. et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes Metab. 46, 403\u2013405 (2020).","journal-title":"Diabetes Metab."},{"key":"235_CR29","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.2337\/dc20-0723","volume":"43","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care 43, 1408\u20131415 (2020).","journal-title":"Diabetes Care"},{"key":"235_CR30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00125-020-05216-2","volume":"63","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia 63, 2486\u20132487 (2020).","journal-title":"Diabetologia"},{"key":"235_CR31","unstructured":"Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control & Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 41, 145\u2013151, (2020)."},{"key":"235_CR32","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama, Y. et al. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43, 970\u2013976 (2004).","journal-title":"Hypertension"},{"key":"235_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.HYP.0000124669.02394.72","volume":"43","author":"RM Carey","year":"2004","unstructured":"Carey, R. M. Angiotensin type-1 receptor blockade increases ACE 2 expression in the heart. Hypertension 43, 943\u2013944 (2004).","journal-title":"Hypertension"},{"key":"235_CR34","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23332","volume":"34","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: bioequivalence study findings. J. Clin. Lab. Anal. 34, e23228 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"235_CR35","doi-asserted-by":"publisher","first-page":"30507","DOI":"10.1016\/j.jinf.2020.07.026","volume":"S0163-4453","author":"QB Lu","year":"2020","unstructured":"Lu, Q. B. et al. Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study. J. Infect. S0163-4453, 30507\u20137, https:\/\/doi.org\/10.1016\/j.jinf.2020.07.026 (2020).","journal-title":"J. Infect."},{"key":"235_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016948","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu, C. et al. Could Anti-hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? Data from centers of Southern Italy. J. Am. Heart Assoc. 9, e016948 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"235_CR37","volume":"12","author":"I Solaimanzadeh","year":"2020","unstructured":"Solaimanzadeh, I. Nifedipine and amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19. Cureus 12, e8069 (2020).","journal-title":"Cureus"},{"key":"235_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04776-7","volume":"9","author":"P Donate-Macian","year":"2018","unstructured":"Donate-Macian, P. et al. The TRPV4 channel links calcium influx to DDX3X activity and viral infectivity. Nat. Commun. 9, 2307 (2018).","journal-title":"Nat. Commun."},{"key":"235_CR39","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1128\/JVI.01923-09","volume":"84","author":"M Ueda","year":"2010","unstructured":"Ueda, M. et al. Highly pathogenic H5N1 avian influenza virus induces extracellular Ca2+ influx, leading to apoptosis in avian cells. J. Virol. 84, 3068\u20133078 (2010).","journal-title":"J. Virol."},{"key":"235_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.277","volume":"6","author":"JR Yaron","year":"2015","unstructured":"Yaron, J. R. et al. K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis. 6, e1954 (2015).","journal-title":"Cell Death Dis."},{"key":"235_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.it.2014.02.007","volume":"35","author":"T Horng","year":"2014","unstructured":"Horng, T. Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome. Trends Immunol. 35, 253\u2013261 (2014).","journal-title":"Trends Immunol."},{"key":"235_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceca.2017.05.007","volume":"70","author":"P Maher","year":"2018","unstructured":"Maher, P. et al. The role of Ca(2+) in cell death caused by oxidative glutamate toxicity and ferroptosis. Cell Calcium 70, 47\u201355 (2018).","journal-title":"Cell Calcium"},{"key":"235_CR43","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms20143458","volume":"20","author":"IVG Silva","year":"2019","unstructured":"Silva, I. V. G., de Figueiredo, R. C. & Rios, D. R. A. Effect of different classes of antihypertensive drugs on endothelial function and inflammation. Int. J. Mol. Sci. 20, 3458 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"235_CR44","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/ijms19092465","volume":"19","author":"JA D\u2019Elia","year":"2018","unstructured":"D\u2019Elia, J. A. & Weinrauch, L. A. Calcium ion channels: roles in infection and sepsis mechanisms of calcium channel blocker benefits in immunocompromised patients at risk for infection. Int. J. Mol. Sci. 19, 2465 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"235_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3904\/kjim.2015.404","volume":"32","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. et al. Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study. Korean J. Intern. Med. 32, 497\u2013504 (2017).","journal-title":"Korean J. Intern. Med."},{"key":"235_CR46","doi-asserted-by":"publisher","first-page":"290ra289","DOI":"10.1126\/scitranslmed.aaa5597","volume":"7","author":"LM Johansen","year":"2015","unstructured":"Johansen, L. M. et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 7, 290ra289 (2015).","journal-title":"Sci. Transl. Med."},{"key":"235_CR47","doi-asserted-by":"publisher","first-page":"S588","DOI":"10.1093\/infdis\/jiy332","volume":"218","author":"LE DeWald","year":"2018","unstructured":"DeWald, L. E. et al. The calcium channel blocker bepridil demonstrates efficacy in the murine model of marburg virus disease. J. Infect. Dis. 218, S588\u2013S591 (2018).","journal-title":"J. Infect. Dis."},{"key":"235_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1067","volume":"8","author":"SM Heaton","year":"2019","unstructured":"Heaton, S. M. Harnessing host-virus evolution in antiviral therapy and immunotherapy. Clin. Transl. Immunol. 8, e1067 (2019).","journal-title":"Clin. Transl. Immunol."}],"updated-by":[{"DOI":"10.1038\/s41421-021-00267-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000}}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00235-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T17:36:43Z","timestamp":1697391403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1038\/s41421-020-00235-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.08.20047134","asserted-by":"object"}]},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,22]]},"assertion":[{"value":"10 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41421-021-00267-0","URL":"https:\/\/doi.org\/10.1038\/s41421-021-00267-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"96"}}